Gonadotropin-releasing hormone agonists for prevention of postoperative adhesions: An overview

Gynecological Endocrinology

Volumn 19, Issue 1, 2004, Pages 51-55

  Schindler, A E ^a  

^a Institute for Medical Research and Education Essen   (Germany)

Author keywords

Adhesion prevention; Adhesions; Endometriosis; GnRH agonists; Myoma

Indexed keywords

ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; BASIC FIBROBLAST GROWTH FACTOR; CALCIUM CHANNEL BLOCKING AGENT; DEXTRAN 70; ESTRADIOL; ESTROGEN; FIBRIN; GLUCOCORTICOID; GONADORELIN AGONIST; GROWTH FACTOR; GROWTH HORMONE RELEASING FACTOR; HEPARIN; LEUPRORELIN; PLASMINOGEN ACTIVATOR INHIBITOR; POLITEF; PROMETHAZINE; PROSTAGLANDIN INHIBITOR; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; VASCULOTROPIN;

ADHESION; ANGIOGENESIS; BLEEDING; BLOOD CLOTTING; ENDOMETRIOSIS; FIBRINOLYSIS; GROWTH HORMONE RELEASE; HEALTH CARE COST; HUMAN; IMMUNE RESPONSE; INFERTILITY; INTESTINE OBSTRUCTION; LAPAROSCOPY; LAPAROTOMY; MYOMA; NONHUMAN; OVARY; PERITONEAL CAVITY; PERITONEUM ADHESION; POSTOPERATIVE INFLAMMATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RELIABILITY; REVIEW; VASCULAR RESISTANCE;

ADHESIONS; ANIMALS; BLOOD COAGULATION; ESTROGENS; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFLAMMATION; PELVIS; POSTOPERATIVE COMPLICATIONS;

EID: 4444372731     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/09513590410001725495     Document Type: Review

References (36)

1. Holmdahl L, Risberg B, Beck DE, et al. Adhesions: pathogenesis and prevention - panel discussion and summary. Eur J Surg 1997;163(Suppl. 577):56-62
2. Liakakos T, Thomakos N, Fine PM, et al. Peritoneal adhesions: etiology, pathophysiology and clinical significance. Recent advances in prevention and management. Dig Surg 2000;18:260-73
3. Lower AM, Hawthorn RJS, Ellis H, et al. The impact of adhesions on hospital readmissions over ten years after 8849 open gynaecological operations: an assessment from the Surgical and Clinical Adhesions Research Study. Br J Obstet Gynaecol 2000;107:855-62
4. Menzies D. Postoperative adhesions: their treatment and relevance in clinical practice. Ann R Coll Surg Engl 1993;72:147-53
5. Ellis H, Moran BJ, Thompson JN, et al. Adhesion-related hospital readmissions after abdominal pelvic surgery: a retrospective cohort study. Lancet 1997;353:1476-80
6. Schwemmle K. Ursachen von Verwachsungen im Abdomen. Langenbecks Arch Chir 1990;(Suppl. II):1017-21
7. Banerjee R, Laufer MR. Reproductive disorders associated with pelvic pain. Semin Pediatr Surg 1998;7:52-61
8. Korell M. Aktuelle Adhäsionsprophylaxe in der operativen Gynäkologie. Gynäkologe 2002;35:1218-23
9. Lundorff P, Hahlin M, Kallfelt B, et al. Adhesion formation after laparoscopic surgery in tubal pregnancy: a randomized trial versus laparotomy. Fertil Steril 1991;55:911-15
10. Korell M, Scheidel P, Hepp H. An animal experimental model for adhesion reformation. J Invest Surg 1994;7:409-15
11. Tulandi T, Murray C, Guralnick M. Adhesion formation and reproductive outcome after myomectomy and second look laparoscopy. Obstet Gynecol 1993;82:213-15
12. Drolette CM, Badawy SZ. Pathophysiology of pelvic adhesions. Modern trends in preventing infertility. J Reprod Med 1992;37:107-21
13. Ray FN, Larsen JW, Stillman RJ, Jacobs RJ. Economic impact of hospitalizations for lower abdominal adhesiolysis in the United States in 1988. Surg Gynecol Obstet 1993;176:271-6
14. Ray FN, Demon WG, Thamer M, et al. Abdominal adhesiolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg 1998;186:1-9
15. Thornton MH, Johns DB, Campeau JD, et al. Clinical evaluation of 0.5% ferric hyaluronate adhesion prevention gel for the reduction of adhesions following peritoneal cavity surgery: open-label pilot study. Hum Reprod 1998;13:1480-5
16. El-Saeed M, Hassan M, Abvolmaady Z, et al. High incidence of pelvic adhesions detected by second-look laparoscopy after laparoscopic ovarian drilling. Middle East Fertil Soc J 2000;5:219-25
17. Canis M, Botchorishvili R, Tamburro S, et al. Adhesion prevention in the surgical treatment of pelvic endometriosis. Gynaecol Endosc 2001;10:99-106
18. Grow DR, Coddington CC, Hsiu J-G, et al. Role of hypoestrogenism or sex steroid antagonism in adhesion formation after myometrial surgery in primates. Fertil Steril 1996;66:140-7
19. Energeli MH, Kuscu E, Zeyneloglu HB, et al. GnRH for adhesion formation after uterine serosal injury in an euestrogenic milieu. J Reprod Med 2000;45:35-8
20. Canbaz MA, Üstün C, Kocak I, Yanik FF. The comparison of gonadotropin-releasing hormone agonist therapy and intraperitoneal Ringer's lactate solution in prevention of postoperative adhesion formation in rat models. Eur J Obstet Gynecol Reprod Biol 1999;82:219-22
21. Wright JA, Sharpe-Timms KL. Gonadotropin-releasing hormone agonist therapy reduces postoperative adhesion formation and reformation of the adhesiolysis in rat models for adhesion formation and endometriosis. Fertil Steril 1995;63:1094-100
22. Sharpe-Timms KL, Zimmer RL, Jolliff WJ, et al. Gonadotropin-releasing hormone agonist (GnRH-a) therapy alters activity of plasminogen activators, matrix metallproteinases, and their inhibitors in rat models for adhesion formation and endometriosis: potential GnRH-a-regulated mechanisms reducing adhesion formation. Fertil Steril 1998;69:916-23
23. Winkler U, Bühler K, Koslowski S, et al. Plasmatic haemostasis in gonadotrophin-releasing hormone analogue therapy: effects of leuprorelin acetate depot on coagulatory and fibrinolytic activities. Clin Ther 1992;14(Suppl. A):114-20
24. Sulaiman H, Dawson L, Laurent GJ, et al. Role of plasminogen activators in peritoneal adhesion formation. Biochem Soc Trans 2002;30:126-31
25. Chegini N, Gold LI, Williams RS, Masterson BJ. Localization of transforming growth factor-β isoforms TGF-β1, TGF-β2 and TGF-β3 in surgically induced pelvic adhesions in the rat. Obstet Gynecol 1994;83:449-54
26. Murphy J, Ghahary A. Uterine insulin-like growth factor: I. Regulation of expression and its role in estrogen uterine proliferation. Endocrinol Rev 1990;11:443-53
27. Iwamoto I, Imada A. Effects of growth factors in proliferation of cultured mesothelial cells. Nippon Jinzo Gakkai Shi 1992;34:1201-8
28. Meresman GF, Bilotas MA, Lombardi E, et al. Effect of GnRH analogues on apoptosis and release of interleukin-1β and vascular endothelial growth factor in endometrial cell cultures from patients with endometriosis. Hum Reprod 2003;18:1767-71
29. Sakamoto Y, Harada T, Horie S, et al. Tumor necrosis factor-α- induced interleukin-8 (IL-8) expression in endometrotic stromal cells, probably through nuclear factor-κB activation: gonadotropin-releasing hormone agonist treatment reduced IL-8 expression. J Clin Endocrinol Metab 2003;88:730-5
30. Wiczyk HP, Grow DR, Adams LA, et al. Pelvic adhesions contain sex steroid receptors and produce angiogenesis growth factors. Fertil Steril 1998;69:511-16
31. Alleem FA, Predanic M. The hemodynamic effect of GnRH agonist therapy on uterine leiomyoma vascularity: a prospective study using transvaginal color Doppler sonography. Gynecol Endocrinol 1995;9:253-8
32. Di Zerega GS. Contemporary adhesion prevention. Fertil Steril 1994;61:219-35
33. Henzl MR, Corson SL, Moghissi K, et al. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med 1988;318:485-9
34. Kuhlmann M, Gärtner A, Regidor PA, et al. Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy. Gynecol Endocrinol 1997;11:169-74
35. Rickes D, Nickel I, Kropf S, Kleinstein J. Increased pregnancy rates after ultralong postoperative therapy with gonadotropin-releasing hormone analogs in patients with endometriosis. Fertil Steril 2002;78:757-62
36. Lin J, Sun C, Zheng H. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility. Chin Med J 2000;113:442-5